000 | 00852 a2200241 4500 | ||
---|---|---|---|
005 | 20250513150150.0 | ||
264 | 0 | _c19980903 | |
008 | 199809s 0 0 eng d | ||
022 | _a0959-8138 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWillis, E | |
245 | 0 | 0 |
_aInfluenza vaccination policy and high risk subjects. Targeting and delivery should remain in general practice. _h[electronic resource] |
260 |
_bBMJ (Clinical research ed.) _cAug 1998 |
||
300 |
_a349-50; author reply 350 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aFamily Practice |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfluenza Vaccines |
650 | 0 | 4 |
_aInfluenza, Human _xprevention & control |
650 | 0 | 4 | _aUnited Kingdom |
650 | 0 | 4 | _aVaccination |
773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 317 _gno. 7154 _gp. 349-50; author reply 350 |
|
999 |
_c9651020 _d9651020 |